Top Authors

• Most frequent coverage on EPIX

• 
  Mike Havrilla (1908 followers)

  • FDA, Clinical Trial Calendar Updates: SOMX, EPIX, HLUKY, ARKTF (Wed, Apr 8)
  • Updated FDA Decision Calendar: Five Decisions Before Year-End (Sun, Dec 28)

  More by Mike Havrilla on EPIX »
• 
  Aaron Katsman (46 followers)

  • EPIX Pharmaceuticals Makes a Significant Altzheimer's Discovery (Sun, Dec 23)

  More by Aaron Katsman on EPIX »
• 
  Douglas Goldstein (6 followers)

  • FDA Closer to Approval of EPIX's Vasovist (Mon, Jul 2)

  More by Douglas Goldstein on EPIX »

• Most followed authors on EPIX

• 
  Mike Havrilla (1908 followers)

  • FDA, Clinical Trial Calendar Updates: SOMX, EPIX, HLUKY, ARKTF (Wed, Apr 8)
  • Updated FDA Decision Calendar: Five Decisions Before Year-End (Sun, Dec 28)

  More by Mike Havrilla on EPIX »
• 
  M. E. Garza (508 followers)

  • Epix Surrenders Battle to Keep Alzheimer's Program Afloat (Mon, Oct 19)

  More by M. E. Garza on EPIX »
• 
  The Burrill Report (173 followers)

  • VC Financings Boost Interest in Biotech (Fri, Jul 24)

  More by The Burrill Report on EPIX »

• Newest authors on EPIX

• 
  M. E. Garza (508 followers)

  • Epix Surrenders Battle to Keep Alzheimer's Program Afloat (Mon, Oct 19)

  More by M. E. Garza on EPIX »
• 
  The Burrill Report (173 followers)

  • VC Financings Boost Interest in Biotech (Fri, Jul 24)

  More by The Burrill Report on EPIX »
• 
  Douglas Goldstein (6 followers)

  • FDA Closer to Approval of EPIX's Vasovist (Mon, Jul 2)

  More by Douglas Goldstein on EPIX »

• Most commented on EPIX

• 
  Mike Havrilla (1908 followers)

  • FDA, Clinical Trial Calendar Updates: SOMX, EPIX, HLUKY, ARKTF (Wed, Apr 8)
  • Updated FDA Decision Calendar: Five Decisions Before Year-End (Sun, Dec 28)

  More by Mike Havrilla on EPIX »
• 
  M. E. Garza (508 followers)

  • Epix Surrenders Battle to Keep Alzheimer's Program Afloat (Mon, Oct 19)

  More by M. E. Garza on EPIX »